McKinley Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

McKinley Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-112,100	Closed	-$1.43M	–	363
2015 Q3	$1.43M	Buy	+112,100	New	+$1.39M	0.07%	197
2014 Q2	–	Sell	-135,800	Closed	-$1.19M	–	375
2014 Q1	$1.19M	Buy	135,800 +107,835	+386%	+$938K	0.05%	214
2013 Q4	$229K	Buy	27,965 +480	+2%	+$3.8K	0.01%	341
2013 Q3	$208K	Buy	27,485 +1,875	+7%	+$13.6K	0.01%	330
2013 Q2	$194K	Buy	+25,610	New	+$187K	0.01%	310

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

McKinley Capital Management's RDY Position: Q4 2015 in Review

McKinley Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 112,100 shares — an estimated $1.43M sold.

McKinley Capital Management first reported a position in RDY in Q2 2013 and held it in 5 quarters. The position peaked at $1.43M in Q3 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

McKinley Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
McKinley Capital Management sold 112,100 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $1.43M.
McKinley Capital Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 5 quarters.
McKinley Capital Management's Dr. Reddy's Laboratories position peaked at $1.43M in Q3 2015.
174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on McKinley Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.